RZNOMICS
Live / Registered — Registered (as of 14 Dec 2021)
What this means for you
Registered since 14 Dec 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79300505
- Registration number
- 6585436
- Mark type
- Design + words
- Filed
- 13 Nov 2020
- Published for opposition
- 28 Sept 2021
- Registered
- 14 Dec 2021
- Attorney of record
- Kisuk Lee
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic preparations; pharmaceutical products for the treatment of viral and infectious disease, for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceuticals for the treatment of cancer disease, neurodegenerative disease, neurodevelopmental disorder, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease; pharmaceutical preparations acting on the central nervous system for the treatment of dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuromuscular disorders, neurodevelopmental disorders, neurovascular disease; anti-cancer preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the use in hematology; anti-diabetic pharmaceuticals; pharmaceutical products for the treatment of infectious disease; anti-dermoinfectives; pharmaceutical preparations for the treatment of kidney disease; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations in the nature of autonomic drugs for medical purposes; pharmaceutical products for treating respiratory disease; pharmaceutical preparations for treating epidermal problems; viral vaccines; anti-viral agents, namely, anti-viral disinfectants; pharmaceutical and veterinary preparations for the treatment of cancer disease, neurodegenerative disease, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous disease; scientific research for medical purposes in the area of cancerous disease; research and development in the fields of pharmaceutical and biotechnology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; research on the subject of pharmaceuticals; clinical studies of medicines, namely, clinical research in the field of cancer therapy, neurodegenerative disease therapy, neurodevelopmental disorder therapy, eye disease therapy, muscular disease therapy, infectious disease therapy, cardiovascular disease therapy, gastrointestinal disease therapy, blood disease therapy, metabolic disease therapy, immune disease therapy, genetic disease therapy, radiology, chemotherapy; medical research services for assessing the efficiency of pharmaceuticals; pharmaceutical drug development services; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medicine research, namely, research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of medical products; providing information on the test, inspection, and research of medical products; consultation and providing information in the fields of pharmacology; industrial research in the fields of medicine, health and pharmacology; analysis of human tissues for medical research
Owner
- Rznomics Inc., KR
- Rznomics Inc., KR
- Rznomics Inc., KR
Prosecution history
- 21 Jun 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 27 May 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 May 2022 — FINAL DISPOSITION PROCESSED
- 14 Mar 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Dec 2021 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Sept 2021 — PUBLISHED FOR OPPOSITION
- 08 Sept 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Aug 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Aug 2021 — EXAMINER'S AMENDMENT ENTERED
- 24 Aug 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Aug 2021 — EXAMINERS AMENDMENT E-MAILED
- 24 Aug 2021 — EXAMINERS AMENDMENT -WRITTEN
- 24 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED